Becoming a Physician-Entrepreneur

Q&A begins
Featured Experts
    Transforming Healthcare With Practical Innovation
    Transforming Healthcare With Practical Innovation
    • Senior Vice President, Corporate Development at American Well

    Jeff leads corporate and business development for American Well, the leading video-based telehealth solution company in the United States. Jeff is responsible for strategic partnerships, investor due diligence, major client deals, M&A opportunities, and corporate strategy. Jeff brings to American Well more than 20 years of experience in healthcare, high tech, and business management and consulting. Prior to joining American Well, he led efforts in business and clinical analytics and population health at MEDITECH. He also has extensive experience in e-commerce and software services, including leadership roles at GSI Commerce and Idiom Technologies. Prior to that, Jeff was an Associate Partner at McKinsey & Company where he focused on healthcare and high-growth technology companies. He graduated from Harvard University with an MD from Harvard Medical School and a PHD, AM, and an AB Summa Cum Laude in Applied Mathematics. He completed his surgical internship at the Harvard-affiliated New England Deaconess Hospital before transitioning to the business world.

    • Geriatric Medicine
    • Internal Medicine
    • Hospital Medicine (Hospitalist)
    Chief of Hospital Medicine at MGH
    Chief of Hospital Medicine at MGH

    Melissa Mattison, MD, SFHM, FACP is a graduate of Tufts University School of Medicine and completed her residency and chief medical residency at the Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. She completed a fellowship in Geriatrics at the Harvard Division on Aging and has a special interest in the care of hospitalized elders. Dr. Mattison is the Chief of Hospital Medicine at Massachusetts General Hospital in Boston. 

    • Internal Medicine
    • Pulmonary Disease
    Co-Founder & CMO of Uniphy Health Systems, LLC
    Co-Founder & CMO of Uniphy Health Systems, LLC

    Dr. Hochron co-founded and is the Chief Medical Officer of Uniphy Health. Stuart received his MD degree from New York Medical College, his JD degree from Rutgers Law School, founded several medical group practices, represented physicians and hospital organizations as a health care attorney and serves as Clinical Professor in the Department of Medicine at UMDNJ-Rutgers Medical School. His company, Uniphy Health, provides software communication technology to healthcare systems. Stuart’s approach to mobile technology has been featured in the Wall Street Journal, the New York Times, the Journal of mHealth, Healthcare IT News, the Healthcare Financial Management Association, the American College of Healthcare Executives, the New York eHealth Collaborative, and mHealthNews.

    • Neurological Surgery
    • Startups
    • Neuroscience
    Neurosurgery Chief Resident, Co-Founder of NeuroLaunch accelerator
    Neurosurgery Chief Resident, Co-Founder of NeuroLaunch accelerator
    • Co-Founder at NeuroLaunch
    Dr. Jordan P. Amadio is a senior resident physician in the Department of Neurosurgery at Emory University and co-founder of NeuroLaunch, the world’s first neuroscience startup company accelerator. Dr. Amadio is a graduate of Princeton University, where he received an honors degree in Physics and was a Barry Goldwater Scholar. In 2004, he was the recipient of both the Kusaka Memorial Prize in Physics as well as the Taylor Prize in Physics. He earned his M.D. degree from Harvard Medical School, where he was a research fellow in the neurogenetics laboratory of Christopher A. Walsh and was selected to complete his training in the Health Sciences and Technology (HST) program co-administered by the Massachusetts Institute of Technology. Simultaneously, he graduated with a Masters in Business Administration, with Distinction, from Harvard Business School as a joint degree candidate. Dr. Amadio’s professional experience includes leadership in the areas of neurosurgery, bioethics, medical education, biomedical technology innovation, and health entrepreneurship. His list of peer-reviewed scientific publications includes research on electrolyte disturbances after pituitary surgery, socioeconomic dimensions of neuromodulation, and the role of guidelines in promoting surgical quality. His popular writing has appeared in media outlets including the Associated Press, The Independent, Natural History, Cell, and various blogs. In the world of medical publishing, he serves as Editorial Fellow and Section Editor at NEUROSURGERY, a leading global academic journal, and has been a strong advocate of interdisciplinary collaboration. In 2014, he edited the first-ever theme issue of the American Medical Association (AMA) Journal of Ethics devoted to neurosurgery. In 2015, he became one of 80 delegates crafting the global BEINGS consensus declaration on responsible use of biotechnology for the next century. In 2014, Dr. Amadio received the American Medical Association Foundation’s Excellence in Medicine Award recognizing his leadership in the early-stage medical innovation community. He has been named “40 under 40” by the Atlanta Business Chronicle as well as “40 under 40 Healthcare Innovators” by MedTechBoston. He serves on the board of several nonprofit organizations, including those supporting the arts and urban renewal in the Southeast. His current research interests lie at the interface of emerging technologies and the human nervous system, including neuromodulation, wearable computing, and applying startup principles to neuroscience innovations. As of June 2015, his work with NeuroLaunch has resulted in 11 accelerated startups and over $4 million in value created.
    • Cardiovascular Disease
    • Internal Medicine
    • Chief Medical Officer at Press Ganey

    Thomas Lee is a practicing internist and cardiologist at Brigham and Women’s Hospital in Boston. He is Chief Medical Officer for Press Ganey, and a Professor (part-time) at Harvard Medical School, a member of the Editorial Board of The New England Journal of Medicine, and the Board of Directors of Geisinger Health System and HealthLeads.

    • Neonatal-Perinatal Medicine
    • Pediatrics
    • Clinical Genomics
    CMO of St. Louis Children's Hospital, Chief of the Division of Newborn Medicine
    CMO of St. Louis Children's Hospital, Chief of the Division of Newborn Medicine
    • Chief Medical Officer at St. Louis Children’s Hospital

    F. Sessions Cole is the Chief Medical Officer at St. Louis Children's Hospital, and Assistant Vice Chancellor for Children's Health, Executive Vice Chairman of the Department of Pediatrics, and Chief of the Division of Newborn Medicine at Washington University School of Medicine, where he oversees the 120-bed neonatal intensive care unit (NICU). Dr. Cole is a leading national advocate for prevention of premature birth and the importance of family partnerships in care for critically ill newborn infants. Dr. Cole has been featured in the Wall Street Journal, New York Times, on ABC World News Tonight and has served as a contributing writer to ABC News Health. Dr. Cole's current research efforts focus on leveraging state of the art genomic sequencing and computational analysis strategies as well as high throughput model system screening methods to apply precision medicine to newborn infants. Using these approaches and extramural support from the NIH and the Children's Discovery Institute, he has contributed to the discovery of genomic variants associated with progressive respiratory failure in term and near term infants and with extreme, undiagnosed birth defect phenotypes.

  • Dr. Bahagon is a clinically active Family Physician, a serial entrepreneur and considered a Key Opinion Leader in the fields of e- health, m-Health & Tele-Care. Dr. Bahagon founded and managed Clalit Health Services (CHS) Digital Health division which led the nationwide transformation of the Israeli healthcare system on both the medical team and the patient levels. CHS is the second largest Health Maintenance Organization in the world, second only to Kaiser Permanente in States. Under Dr. Bahagon’s leadership, CHS Digital Health suite became a benchmark for nationwide Digital Health platforms, with millions of patients using it on a monthly basis, for tens of million interactions each month. CHS Digital Health suite has created a dramatic change at both patient and the healthcare system levels, with proven outcomes in clinical quality, as well as in efficiency, availability, accessibility and transparency of health care delivery. Dr. Bahagon founded and managed Luminox (acquired) – a leading Israeli Digital Health startup hub and a strategic digital health consulting firm that serves leading international pharma, healthcare providers and insurers, and giant tech companies. Following its acquisition, Dr. Bahagon had co-founded Qure – a ‎‎$50M fund focusing on early stage digital health solutions. ‎ Additionally, Dr. Bahagon has also been a founding member of several successful digital health startups, among ‎them – TytoCare, Medisafe, Sweetch and others. ‎ Dr. Bahagon serves as an advisory board member of Biocat's Digital Health Accelerator in Barcelona, Editorial Board Member of the UK eHealth Law & Policy Journal, and a mentor at Microsoft's Think- Next Accelerator and the brain-tech accelerator Brainnovation.

    • medical writing
    • Teaching
    • Research
    • Public Speaking
    • Writing
    • Mandarin Chinese (Conversational Fluency)
    • EMT-B trained
    Founder & President @ Doctors Who Create; MS3 @ UPenn
    Founder & President @ Doctors Who Create; MS3 @ UPenn

    Vidya Viswanathan is the founder and president of Doctors Who Create (www.doctorswhocreate.com), which promotes a culture of creativity in medicine. She is a rising fourth-year medical student at the Perelman School of Medicine (University of Pennsylvania), and is the 2018-2019 Artist-in-Residence for the American Medical Women's Association. She enjoys writing about medicine and innovation, and has published her writing in The Atlantic, MedTech Boston, Academic Medicine, and The Establishment. She has presented on creativity in medicine at the conferences Stanford MedX, AMSA National, and the Hippocrates Poetry Symposium. Vidya graduated from Harvard College in 2011 with a degree in Social Studies and citation in Mandarin Chinese, and spent a year in Taiwan after graduation teaching English on a Fulbright fellowship. She did her post-bacc pre-med classes at the Harvard Extension School.

    • Internal Medicine
    • Primary Care
    • Innovation
    • mHealth
    • Prehospital Care
    • EMS
    Founder of Twiage, Practicing Internist @ Atrius Health
    Founder of Twiage, Practicing Internist @ Atrius Health

    YiDing Yu a practicing primary care physician, researcher, innovator, entrepreneur, and designer. She was Founder and CEO of Twiage and formerly Chief Innovation Engineer at Atrius Health. As a physician, YiDing is passionate about improving health care delivery to provide timely, high-quality, cost-effective care to her patients. She has received the President's Prize for Value-Based Healthcare at Partners Healthcare, the Martin P. Solomon Award for Primary Care at the Brigham and Women's Hospital, and the Massachusetts Medical Society Information Technology Award in recognition of her work in healthcare innovation. YiDing has been named a 40 Under 40 Healthcare Innovator, a 40 Under 40 Honoree by the Boston Business Journal, and Becker's Hospital Review Rising Star. Trained in economics and health policy at Harvard, YiDing has conducted research as a Doris Duke Clinical Research Fellow, published in medical journals, presented at national conferences, and was most recently recognized by the Johns Hopkins Diane Becker Research Award in Clinical Epidemiology. As a resident, YiDing founded Twiage, a HIPAA-compliant platform that seamlessly bridges communication between ambulances and hospitals to deliver more timely and cost-effective patient care at the most crucial moments. In her free time, YiDing designs and volunteers for philanthropic causes. She is a Board Member for Burma Border Projects, a non-profit organization dedicated to providing trauma counseling and mental health support for refugees and internally displaced persons in Burma.

    • Endocrinology, Diabetes and Metabolism
    • Internal Medicine
    • Technology, Innovation and Education
    Senior Partner, Takeda Ventures
    Senior Partner, Takeda Ventures
    • Senior Partner at Takeda Ventures, Inc.

    Dr. Shaywitz is a graduate of Harvard College (summa cum laude), and received his MD from the Health Sciences and Technology program at Harvard Medical School and MIT, and his PhD from the Department of Biology at MIT. He trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard. He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group’s Healthcare and Corporate Development practices, where he focused on strategy and organizational design. Most recently, he was Senior Director of Strategic and Commercial Planning and Corporate and Business Development at Theravance, a publicly-held drug development company in South San Francisco, where he concentrated on new product development and led a product team. Currently, he is Chief Medical Officer of Mountain View-based DNAnexus, where he focuses on delivering upon the collaborative, patient-inspired vision of genome-enabled (really, data-enabled) medicine. Dr. Shaywitz is a co-founder (with Dennis Ausiello) of the Harvard PASTEUR program, a translational research initiative at Harvard Medical School. He is also a founding advisor of Sage, a non-profit medical research initiative (founded by Eric Schadt and Stephen Friend) emphasizing networks and open innovation (www.sagebase.org). More recently, he co-founded the Center for Assessment Technology and Continuous Health (CATCH), a MGH/MIT-based digital health initiative led by Dennis Ausiello, and focused on using improved real-world phenotypic assessment to improve care and advance science. For the last fifteen years, Dr. Shaywitz has contributed commentaries about medicine, science, strategy, innovation and digital health to a number of popular publications, including The New York Times, The Washington Post, The Wall Street Journal, Politico Pro, and The Financial Times. He currently is a regular contributor to Forbes.com and TheAtlantic.com. Dr. Shaywitz is an Adjunct Scholar at the American Enterprise Institute, and is a political independent. His email is: david {dot} shaywitz {at} gmail {dot} com.

    • Family Medicine
    CEO of Gold Direct Care
    CEO of Gold Direct Care
    • CEO at Gold DirectCare
    Jeffrey Gold, MD, is a Clinical Instructor in the Department of Public Health and Family Medicine at Tufts University School of Medicine and is the CEO of Gold Direct Care. Gold Direct Care will be the first direct primary care practice in Massachusetts. Dr. Gold received his MD at the University of Massachusetts Medical School. He is currently a member of the Massachusetts Medical Society and the American Academy of Family Physicians.
    • Family Medicine
    • Direct Primary Care
    CEO, Physician at AtlasMD
    CEO, Physician at AtlasMD
    • Owner, Physician at AtlasMD
    Born and raised in Alma, Kansas, Josh Umbehr, MD, majored in human nutritional sciences with a minor in biology, and completed extensive research on the effects of vitamin A on lung cancer. He graduated from The University of Kansas School of Medicine and completed his Family Medicine residency at Wesley Medical Center. After completing his training to become a Board Certified Family Physician, he opened Atlas MD. His cash-only clinic embodies his ideal medical practice, one where he shrugs off the burdens and restrictions of government regulation daily. That way he can focus solely on his patients.
  • September Wallingford is the Director of Operations for Costs of Care. She is also a registered nurse at Brigham and Women's Hospital in Boston, Massachusetts. September believes nurses play a vital role in creating value for patients and their families. She advocates for nurses to be full, collaborative partners in high value care. She holds a Master of Science in Nursing from the University of Massachusetts-Boston and a Bachelor of Science in Nursing from The Ohio State University.
    • Internal Medicine
    • General Manager & Chief Medical Officer, New Markets at CareMore Health

    Vivek Garg, MD, MBA, is General Manager & Chief Medical Officer, New Markets at CareMore Health System and a practicing internist. CareMore Health System is a national care delivery organization and integrated health plan serving over 150,000 high-risk members in 8 states across Medicare and Medicaid. Dr. Garg leads strategy and operations for CareMore's expansion markets including managed Medicaid and health system partnerships. He is dedicated to the goal of humanizing healthcare and achieving the triple aim, through patient-centered care delivery redesign. He also serves as an advisor to early-stage healthcare start-ups. Previously, Dr. Garg was Director of Medical Operations & Medical Director at Oscar Insurance - a high-growth, consumer-focused and technology-enabled healthcare company focused on redesigning the health insurance and care delivery experience. He was also Clinical Assistant Professor of Medicine at Weill Cornell Medical College. Prior to Oscar, Dr. Garg was Medical Director at One Medical Group, a nationally recognized, rapidly growing primary care system, where he led initiatives in quality, population health, and telemedicine. His prior work experience spans the public, private, and non-profit sectors, including positions with McKinsey & Company and the Medicare Payment Advisory Commission, a leading Congressional advisory body on payment innovation in Medicare. He trained in internal medicine at Brigham & Women's Hospital, where he practiced primary care at Faulkner Hospital and was a clinical fellow at Harvard Medical School. He received his MD and MBA from Harvard Medical School and Harvard Business School, respectively, and graduated summa cum laude from Yale University.

    • General Practice
    • Strategy Consulting
    • Quality Improvement
    • Startups
    • Technology, Innovation and Education
    • Health Care Administration
    • CEO, CMO, CMIO, CQO, Consultant, Innovation, Equity Arrangement
    Executive Director at Healthbox / Healthbox Global Partners
    Executive Director at Healthbox / Healthbox Global Partners

    Professional Experience: Dr. Silobrcic has over 25 years of healthcare experience. He is a seasoned professional, with clinical background as physician, and extensive experience at the forefront of strategy, operations and services and technology management. Dr. Silobrcic is Executive Director of Healthbox, where he focuses on Boston/the Northeast. Healthbox (www.healthbox.com) is a leading platform for healthcare innovation, and drives actionable collaboration between technology entrepreneurs, the healthcare industry, and investors, in building a global community dedicated to driving change in healthcare. Previously, Dr. Silobrcic was Associate Partner, Strategy and Senior Medical Scientist, Care Delivery Systems, at IBM Research, where he used his deep healthcare industry expertise to help lead a market-focused research agenda that created high value solutions for IBM, providing transformative value to clients and health systems, globally. This included work on IBM’s Health and Wellness solutions for Smarter Cities and Communities, and on advanced healthcare analytics solutions, including the healthcare applications of IBM's breakthrough Watson technology. Formerly, he was an Associate Partner in strategy, operations and change management with major international professional services (consulting) firms, Deloitte Consulting and IBM Global Business Services. Previous to and between those roles, he was a senior executive with or advisor to various healthcare ventures, including a number of healthcare information technology startups. As leader, he has led organizations/teams, various programs, projects and intellectual capital development efforts, as well as leadership development and assessment initiatives. As executive, he has held senior roles (including as CEO) in healthcare technology and services entities, with responsibilities in general management, business development, operations and financial management, people management, etc. As consultant/advisor, he has worked with leading private and public sector healthcare providers, payers and life sciences entities, specializing in strategy, governance, operations management/redesign, organizational transformation and change management, quality management, etc. He has also assisted a number of young healthcare technology and services companies in diverse aspects of their development and management, and acted as healthcare industry/technology advisor to a prominent investment network. As clinician, he has provided patient care as a general medical/primary care physician. As educator, he has developed and taught management courses for physician executives, with a particular focus on quality management/improvement, at Harvard University; as researcher, he has authored presentations, publications and case management studies, and holds several patents. Graduate Education: Harvard University, Master of Science in Healthcare Management (M.S.); Harvard University, Master of Public Health (M.P.H.); University of Zagreb Medical School, Doctor of Medicine (M.D.).